Log in to save to my catalogue

Empyema in a patient treated with infliximab: it is not what it seems

Empyema in a patient treated with infliximab: it is not what it seems

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1755261

Empyema in a patient treated with infliximab: it is not what it seems

About this item

Full title

Empyema in a patient treated with infliximab: it is not what it seems

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

Journal title

Annals of the rheumatic diseases, 2005-11, Vol.64 (11), p.1657-1658

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd and European League Against Rheumatism

More information

Scope and Contents

Contents

Reduced IgG levels can be the result of long term prednisone treatment or chronic infection. 1 Isolated IgG2 subclass deficiency may result in enhanced susceptibility to encapsulated bacteria. 2 Another report suggests an increased susceptibility to invasive pneumococcal disease in homozygotes for MBL codon variants. 3 It is tempting to speculate t...

Alternative Titles

Full title

Empyema in a patient treated with infliximab: it is not what it seems

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1755261

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1755261

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/ard.2004.034959

How to access this item